Skip to main content
< Back
About
About the conference
App
Organisers & Partners
Latest updates
Press room
Registration
Venue 22
About the venue
Rooms
Call for abstracts
Programme 22
Tracks 22
Speakers 22
Side events 22
Subscribe
days
hours
minutes
seconds
Policy
Sessions
Wednesday, 23 November
10:50
Drug policy: socio-political influence, cultural diversity
10:50
to
12:20
Insights zone 1 (I1)
InterGLAM cinema
Current and future challenges associated with emerging cannabis markets
10:50
to
12:20
Main stage
Structured session
Emerging changes in Europe's cannabis situation: policy preparedness and responses to a dynamic situation
10:50
to
12:20
Knowledge market 4 (K4)
Structured session
13:20
Assessing the impact of laws and policies regulating illicit drugs on health and society: some insights
13:20
to
14:50
Knowledge market 4 (K4)
Structured session
Drug use in diverse communities and settings
13:20
to
14:50
Networking zone 1 (N1)
e-poster guided tour
Policies for regulating cannabis supply in Europe and the US: the need for appropriate monitoring and evaluation
13:20
to
14:50
Knowledge market 1 (K1)
Structured session
15:00
Convergence in behavioural addictions
15:00
to
16:30
Main stage
Structured session
How prepared are monitoring systems to respond to rapidly changing drug markets in regions bordering the European Union?
15:00
to
16:30
Insights zone 4 (I4)
Structured session
Implementation of quality standards in drug demand reduction – where we are and where we are going?
15:00
to
16:30
Knowledge market 1 (K1)
Structured session
Scenario Engagement Workshop
15:00
to
16:30
Central square 4 (C4)
Workshop
Spillover effects of drug policy and why better data are needed
15:00
to
16:30
Networking zone 1 (N1)
e-poster guided tour
Surveillance
15:00
to
16:30
Networking zone 4 (N4)
Short communication session
Towards endemicity: A global perspective of the many variants of drug consumption rooms and service models in operation
15:00
to
16:30
Insights zone 3 (I3)
Structured session
16:50
Assessment of drug policies in light of Sustainable Development Goals and human rights
16:50
to
18:20
Knowledge market 1 (K1)
Structured session
Driving under the influence of cannabis (DUIC)
16:50
to
18:20
Insights zone 3 (I3)
Structured session
Scanner - Understanding the dynamics and consequences of new psychoactive substances in a rapidly changing (online) drug market
16:50
to
18:20
Insights zone 4 (I4)
Structured session
Thursday, 24 November
09:00
Contemporary Issues
09:00
to
10:30
Central square 2 (C2)
Oral presentation session
Developing the addiction workforce in Africa: Progress and Issues
09:00
to
10:30
Central square 4 (C4)
Workshop
10:50
Alcohol policies
10:50
to
12:20
Central square 1 (C1)
Oral presentation session
Cannabis use and purchase behaviours in Canada, United States, Australia, and New Zealand: Findings from the International Cannabis Policy Study
10:50
to
12:20
Knowledge market 1 (K1)
Structured session
From Harm to Risk Reduction: OKANA’s 360o approach in Athens
10:50
to
12:20
Knowledge market 4 (K4)
Structured session
New frontiers of harm reduction in drug policy
10:50
to
12:20
Networking zone 2 (N2)
e-poster guided tour
Successful systemic management for addiction challenges and all its side effects
10:50
to
12:20
Central square 4 (C4)
Structured session
13:20
Cannabis Social Clubs: current experiences and future directions
13:20
to
14:50
Knowledge market 4 (K4)
Structured session
Environmental prevention: why do we need it now and how to advance it?
13:20
to
14:50
Insights zone 2 (I2)
Structured session
Shifting markets and drug trafficking
13:20
to
14:50
Networking zone 2 (N2)
e-poster guided tour
15:00
Alcohol epidemiology and interventions
15:00
to
16:30
Networking zone 3 (N3)
Short communication session
Drug deaths: A social, structural and systems analysis
15:00
to
16:30
Knowledge market 1 (K1)
Structured session
InterGLAM video session
Policy and practice to tackle addictions around the world
15:00
to
16:30
Insights zone 1 (I1)
InterGLAM cinema
The global gambling industry: Structures, tactics, and networks of impact
15:00
to
16:30
Insights zone 3 (I3)
Structured session
16:50
Innovative approaches to tackling the drug overdoses
16:50
to
18:20
Knowledge market 1 (K1)
Oral presentation session
New frontiers to regulating cannabis for public health and social justice
16:50
to
18:20
Insights zone 2 (I2)
Oral presentation session
Opportunities and challenges for countries in transition to overcome barriers to evidence-based policies and interventions
16:50
to
18:20
Networking zone 2 (N2)
Structured session
Problem gambling: models and their ethical implications
16:50
to
18:20
Insights zone 3 (I3)
Structured session
Signals from the future: Exploring implications for drug policies
16:50
to
18:20
Central square 4 (C4)
Workshop
Trajectories of cannabis use during periods of policy change
16:50
to
18:20
Central square 2 (C2)
Oral presentation session
Friday, 25 November
09:00
Alcohol addiction; new knowledge on politics, risks, treatments and outcomes
Social inequality in drinking, underage drinking and alcohol industry
09:00
to
10:30
Main stage
Plenary session
10:50
Global Issues - Backcasting exercise
10:50
to
12:20
Insights zone 1 (I1)
InterGLAM cinema
EUFAS/EAR European Addiction Award
Alcohol - no ordinary commodity, alcohol policies and The Gut-Brain Axis in AUD
10:50
to
12:20
Main stage
Structured session
Gambling, policies and interventions
10:50
to
12:20
Insights zone 3 (I3)
Oral presentation session
Gender differences and gender identities in drug use, addiction and interventions: why gender matters
10:50
to
12:20
Networking zone 3 (N3)
Structured session
Language values and theory in drugs policy reform
10:50
to
12:20
Knowledge market 1 (K1)
Oral presentation session
Portuguese Drug Policy Model. Achievements and challenges
10:50
to
12:20
Central square 2 (C2)
Structured session
13:20
Using innovative data or methods to assess drug markets and drug policy impacts
13:20
to
14:50
Knowledge market 1 (K1)
Oral presentation session
Presentations
Wednesday, 23 November
10:50
Oral presentation
5. Treatment of cannabis-related problems in Europe: a typology and evidence overview
10:50
to
12:20
Knowledge market 4 (K4)
Daniel Feingold
Oral presentation
3. Cannabis-related effects and harms: a scientific overview
10:50
to
12:20
Knowledge market 4 (K4)
Jakob Manthey
Oral presentation
4. Harm reduction for cannabis related problems in Europe and beyond
10:50
to
12:20
Knowledge market 4 (K4)
Iciar Indave
Oral presentation
2. Medical use of cannabis and cannabinoids: an overview of evidence
10:50
to
12:20
Knowledge market 4 (K4)
Mafalda Pardal
Oral presentation
1. Gender-sensitive drug policy
10:50
to
12:20
Insights zone 1 (I1)
Gabriele Fischer
Oral presentation
2. Youth-centered drug policy
10:50
to
12:20
Insights zone 1 (I1)
Danya Fast
Oral presentation
3. Perspectives of people who use drugs on drug policy
10:50
to
12:20
Insights zone 1 (I1)
Mat Southwell
Introduction
1. Setting the scene: recent cannabis policy developments in European countries
10:50
to
12:20
Knowledge market 4 (K4)
Liesbeth Vandam
Introduction
Drug policy: socio-political influence, cultural diversity
10:50
to
12:20
Insights zone 1 (I1)
Abhishek Ghosh
13:20
e-poster
Harm reduction calls to action from young people who use drugs on the streets of Vancouver and Lisbon
13:20
to
14:50
Networking zone 1 (N1)
Joana Canedo
e-poster
Cannabis use and aquisition in pandemic times – results from a sample of regular users in Germany
13:20
to
14:50
Networking zone 1 (N1)
Bernd Werse
e-poster
A retrospective overview of polydrug abuse in Tunisia
13:20
to
14:50
Networking zone 1 (N1)
Bilel Moslah
e-poster
Professionals’ views on challenges in inpatient substance abuse treatment during COVID-19 pandemic
13:20
to
14:50
Networking zone 1 (N1)
Eeva Ekqvist
e-poster
Tipping points surrounding motivation to change substance use patterns among seniors in the general population or with incarceration experience: are they all the same?
13:20
to
14:50
Networking zone 1 (N1)
Valérie Aubut
e-poster
Methodological challenges and policy relevance of studies on substance use in nightlife settings: the case of the Nightlife Study in the Netherlands
13:20
to
14:50
Networking zone 1 (N1)
Karin Monshouwer
e-poster
Incorporating Culture into The Treatment of Substance Use Disorder: A Narrative Review
13:20
to
14:50
Networking zone 1 (N1)
Odete Nombora
e-poster
COVID-19 related stressors and alcohol use among urban refugee youth in Kampala, Uganda
13:20
to
14:50
Networking zone 1 (N1)
Carmen Logie
Oral presentation
5. The U.S. Cannabis Policy Scale: Moving Beyond Dichotomous Measures to Evaluate Impacts of Liberalization Policies on Cannabis and Other Substance Use Outcomes
13:20
to
14:50
Knowledge market 1 (K1)
Rosalie Pacula
Oral presentation
1. Designing a system of monitoring responsible use and distribution of cannabis in Malta
13:20
to
14:50
Knowledge market 1 (K1)
Mariella Dimech
Oral presentation
2. Measuring the impacts of a new cannabis regulation in Luxembourg: the need for valid data collection methods
13:20
to
14:50
Knowledge market 1 (K1)
Nadine Berndt
Oral presentation
3. The Swiss pilot trials with cannabis – evaluation after one year
13:20
to
14:50
Knowledge market 1 (K1)
Maya Ackermann
Oral presentation
4. The Dutch closed cannabis supply chain experiment: background, design of the evaluation study and challenges
13:20
to
14:50
Knowledge market 1 (K1)
Margriet van Laar
Discussion
Adapting monitoring and evaluation to the different versions of 'legalisation', while exploring possible common indicators
13:20
to
14:50
Knowledge market 1 (K1)
Brendan Hughes
Oral presentation
1. Drug laws indicators through the leximetric approach and relationship with effectiveness: the example of Italy in the period 1991-2018
13:20
to
14:50
Knowledge market 4 (K4)
Carla Rossi
Oral presentation
2. Hospitalization risk profile of opioids users
13:20
to
14:50
Knowledge market 4 (K4)
Giada Minelli
Oral presentation
3. Using Supply Indicators in the Evaluation of Drug Supply Reduction – Challenges and Opportunities
13:20
to
14:50
Knowledge market 4 (K4)
Nicola Singleton
Oral presentation
4. Estimating the size of the of illicit drug market – a critical review
13:20
to
14:50
Knowledge market 4 (K4)
Robin Udrisard
Oral presentation
5. Estimating the costs of the criminal justice system
13:20
to
14:50
Knowledge market 4 (K4)
Francesco Fabi
Discussion
Integrating indicators and estimates
13:20
to
14:50
Knowledge market 4 (K4)
Peter H. Reuter
15:00
Short communication
Findings from novel methods of surveillance for fentanyl and novel psychoactive substances within Supervised Injecting Facilities
15:00
to
16:30
Networking zone 4 (N4)
Suzanne Nielsen
Short communication
Detection of Potent 'Nitazene' Synthetic Opioids by a networked drug checking service in Toronto, Ontario, Canada
15:00
to
16:30
Networking zone 4 (N4)
Kristy Scarfone
Short communication
Access to medical cannabis in Brazil: informal regulation via patient associations as a social movement
15:00
to
16:30
Networking zone 4 (N4)
Paulo J. R. Pereira
Short communication
Method development for monitoring Google-indexed e-shops offering new psychoactive substances (NPS) in The Netherlands.
15:00
to
16:30
Networking zone 4 (N4)
Lavinia Stegemann
Oral presentation
1. Key developments in drug markets of North Africa and Middle East
15:00
to
16:30
Insights zone 4 (I4)
Emadeddin Badi
Short communication
How to evaluate complex drug policies? A case study of the Belgian drug policy
15:00
to
16:30
Networking zone 4 (N4)
Eva Blomme
Oral presentation
3. Key developments in drug markets of Western Balkans
15:00
to
16:30
Insights zone 4 (I4)
Robert Patrancus,
Katerina Skarupova
Short communication
The Unit of Cannabis: from a systematic review to a NIDA recommendation
15:00
to
16:30
Networking zone 4 (N4)
María Teresa Pons-cabrera
Oral presentation
5. Changing drug market requires new priorities for Moldova’s law enforcement authorities
15:00
to
16:30
Insights zone 4 (I4)
Vladislav Cojuhari
Short communication
A longitudinal study of a drug checking service for patrons of Boom Festival 2018: behavioral outcomes at individual and group levels.
15:00
to
16:30
Networking zone 4 (N4)
Helena Valente
Oral presentation
2. Lebanon: responding to drug market changes in crisis situation
15:00
to
16:30
Insights zone 4 (I4)
Zeinab Abbas
Short communication
Using Reddit Social Media Data to Uncover Self-medication and Drug Use Trends among Opioid Users: Semi-automated Natural Language Processing Approach.
15:00
to
16:30
Networking zone 4 (N4)
Georgiy Bobashev
Oral presentation
4. Key developments in drug markets of Eastern European Neighbourhood Policy (ENP) countries
15:00
to
16:30
Insights zone 4 (I4)
Daan Van der Gouwe
Oral presentation
1. Quality Assurance Tools: Improving Coverage, Accessibility and Quality of Drug Use Disorder Treatment
15:00
to
16:30
Knowledge market 1 (K1)
Anja Busse
Oral presentation
4. Key factors for a successful implementation of Quality Standards in Drug Demand Reduction – a Delphi Study
15:00
to
16:30
Knowledge market 1 (K1)
Rafaela Rigoni
Oral presentation
2. Further ENhancing the Implementation of Quality Standards in drug demand reduction across Europe (FENIQS-EU) project – study objectives and first realisations
15:00
to
16:30
Knowledge market 1 (K1)
Dijana Jerkovic
Oral presentation
3. State of the Art of Quality Standards implementation in drug demand reduction in Europe
15:00
to
16:30
Knowledge market 1 (K1)
Martina Feric
Oral presentation
5. An inspiring practice example of Quality Standards implementation: the Spanish Good Practice inDemand Reduction Portal (PBBPP)
15:00
to
16:30
Knowledge market 1 (K1)
Alba González-Roz
Discussion
Quality Standards in Drug Demand Reduction – lessons learned and the way forward
15:00
to
16:30
Knowledge market 1 (K1)
Wouter Vanderplasschen
e-poster
Association of the 2016 UK Psychoactive Substance Act with hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure.
15:00
to
16:30
Networking zone 1 (N1)
Sam Craft
e-poster
Is there a long-term relationship between cannabis and heroin use? An 18-20-year follow-up of the Australian Treatment Outcome Study (ATOS)
15:00
to
16:30
Networking zone 1 (N1)
Jack Wilson
e-poster
Do Medical Cannabidiol Laws Reduce Nonfatal and Fatal Opioid Overdose Rates?
15:00
to
16:30
Networking zone 1 (N1)
Rahi Abouk
e-poster
Regulating cannabis : a comparative perspective on policy rollouts and unintended consequences in The United States and Canada (lessons from 6 case studies)
15:00
to
16:30
Networking zone 1 (N1)
Ivana Obradovic
e-poster
The Effects of Recreational Cannabis Laws on Pharmacy- and Hospital-Based Opioid Distribution in the United States
15:00
to
16:30
Networking zone 1 (N1)
Coleman Drake
Oral presentation
1. Convergences in the psychology of behavioral addictions
15:00
to
16:30
Main stage
Matthias Brand
Oral presentation
2. Convergences in the neurobiology of behavioral addictions
15:00
to
16:30
Main stage
Marc N. Potenza
Oral presentation
3. Convergences in the treatment of behavioral addictions
15:00
to
16:30
Main stage
Susana Jiménez-Murcia,
Fernando Fernández-Aranda,
Roser Granero
Oral presentation
4. Convergences in behavioral addiction policies
15:00
to
16:30
Main stage
Sophia Achab
Oral presentation
1. Twenty-one years of operation at the Uniting Sydney Medically Supervised Injecting Centre (MSIC) Australia
15:00
to
16:30
Insights zone 3 (I3)
Marianne Jauncey
Oral presentation
2. The rapid expansion of DCRs/SIFs in Canada in the context of a public health emergency
15:00
to
16:30
Insights zone 3 (I3)
Jane Buxton
Oral presentation
3. Denmark: A successful case study in community advocacy culminating in several sanctioned SIFs
15:00
to
16:30
Insights zone 3 (I3)
Michael Lodberg Olsen
Oral presentation
4. How to run an unsanctioned overdose prevention van; experiences from Glasgow 2020-2021
15:00
to
16:30
Insights zone 3 (I3)
Peter H. Krykant
Discussion
Discussion: synergies and challenges each region faces in relation to the model/s within which DCRs operate
15:00
to
16:30
Insights zone 3 (I3)
Jane Mounteney
Discussion
Convergence in behavioural addictions
15:00
to
16:30
Main stage
Luke Clark
Oral presentation
0. Convergence in behavioural addictions: Introduction
15:00
to
16:30
Main stage
Zsolt Demetrovics
Oral presentation
3 Scenarios, 3 Alternative Addiction Futures for 2040
15:00
to
16:30
Central square 4 (C4)
Jessica Prendergast
16:50
Oral presentation
2. The influence of legislation on the availability of NPS
16:50
to
18:20
Insights zone 4 (I4)
Judith Aldridge
Oral presentation
3. Prevalence of NPS use. Results of the implementation of a standardized survey methodology amongst 25 civil society organization in Europe
16:50
to
18:20
Insights zone 4 (I4)
Jochen Schrooten
Discussion
The importance of the justice programme
16:50
to
18:20
Insights zone 4 (I4)
Koralia Kontou
Oral presentation
1. Analysis of NPS and drugs purchased on Darknet and Clearnet markets
16:50
to
18:20
Insights zone 4 (I4)
Mireia Ventura
Oral presentation
The Global Drug Policy Index
16:50
to
18:20
Knowledge market 1 (K1)
Marie Nougier
Oral presentation
1. International Guidelines on Human Rights and Drug Policy: From standard setting to assessing compliance
16:50
to
18:20
Knowledge market 1 (K1)
Damon Barrett
Oral presentation
2. Pompidou Group for Human rights and drug policies in Europe: A self-assessment tool
16:50
to
18:20
Knowledge market 1 (K1)
Thomas Kattau
Oral presentation
3. The Global Drug Policy Index: A unique accountability tool to assess and rank countries’ drug policies
16:50
to
18:20
Knowledge market 1 (K1)
Juan Fernandez Ochoa
Oral presentation
4. Policy and legislation
16:50
to
18:20
Insights zone 3 (I3)
Brendan Hughes
Oral presentation
5. Medical use and novel cannabinoids
16:50
to
18:20
Insights zone 3 (I3)
Robyn Robertson
Oral presentation
1. Experimental studies on cannabis and driving impairment
16:50
to
18:20
Insights zone 3 (I3)
Tom Arkell
Oral presentation
2. Epidemiological studies on cannabis and crash risk
16:50
to
18:20
Insights zone 3 (I3)
Eef Theunissen
Oral presentation
3. Toxicology: detection of THC impairment
16:50
to
18:20
Insights zone 3 (I3)
Jan Ramaekers
Introduction
Scanner - Understanding the dynamics and consequences of new psychoactive substances in a rapidly changing (online) drug market
16:50
to
18:20
Insights zone 4 (I4)
Margot Balcaen
Thursday, 24 November
09:00
Oral presentation
2. Addiction Curriculum in Nigerian Higher Education System – Contextualizing Western-based methods and approaches for responsiveness and effectiveness.
09:00
to
10:30
Central square 4 (C4)
Martin Agwogie
Oral presentation
3. Piloting an implementation protocol delivered as an online course: African leadership in addiction workforce development
09:00
to
10:30
Central square 4 (C4)
Beatrice Kathungu
Oral presentation
1. Needs Assessment of Addiction Science Programmes at Universities in South Africa and Preparatory work for curriculum development
09:00
to
10:30
Central square 4 (C4)
Rehana Kader
Oral presentation
Stakeholders’ perceptions about their position and the dynamics between the stakeholders within Swedish drug policy field
09:00
to
10:30
Central square 2 (C2)
Tuulia Lerkkanen
Oral presentation
Switching from a criminalisation to a public health approach to injecting drug use in Eastern Europe and Central Asia: a modelling analysis of the costs and impact on HIV transmission
09:00
to
10:30
Central square 2 (C2)
Zoe Ward
Oral presentation
Addressing intimate partner abuse (IPA) perpetrated by heterosexual men in substance use treatment: the ADVANCE programme
09:00
to
10:30
Central square 2 (C2)
Gail Gilchrist
Oral presentation
ROSE: A peer-led intervention to support peer workers in overdose response settings in British Columbia
09:00
to
10:30
Central square 2 (C2)
Fred Cameron
10:50
Oral presentation
Noticed and then forgotten: gender in alcohol policy stakeholder responses to alcohol and violence
10:50
to
12:20
Central square 1 (C1)
David Moore
Oral presentation
Impact of introducing a minimum alcohol tax share in retail prices on alcohol-attributable mortality in the WHO European Region: a modelling study
10:50
to
12:20
Central square 1 (C1)
Pol Rovira Escarrà
Oral presentation
Implementing a Moderate Alcohol Use Program for Indigenous People: A Stakeholder Perspective
10:50
to
12:20
Central square 1 (C1)
Pascale Alarie-vézina
Oral presentation
Simulation of Alcohol Control Policies for Health Equity (SIMAH): Study design and first results
10:50
to
12:20
Central square 1 (C1)
Charlotte Probst,
Robin Purshouse
e-poster
Sin tax in Poland – an example of effectiveness of fiscal measures in alcohol policy
10:50
to
12:20
Networking zone 2 (N2)
Dagmara Lebiecka
e-poster
Myths of drug consumption decriminalization: long-term effects of Portuguese decriminalization on drug-related deaths
10:50
to
12:20
Networking zone 2 (N2)
Lucas Marín-Llanes
e-poster
The association of cannabis marketing exposure with positive cannabis attitudes and cannabis use in the most permissive medical cannabis market in the U.S.
10:50
to
12:20
Networking zone 2 (N2)
Amy Cohn
e-poster
Building harm reduction focused cannabis public education materials: An example of knowledge translation with previously stigmatized communities.
10:50
to
12:20
Networking zone 2 (N2)
Daniel Bear
e-poster
Lessons for Public Health and Public Safety from Fentanyl-Related Substances Scheduling in the United States
10:50
to
12:20
Networking zone 2 (N2)
M.J. Menendez
e-poster
20 years of decriminalisation
10:50
to
12:20
Networking zone 2 (N2)
Américo Gegaloto
Oral presentation
1. The International Cannabis Policy Study – Framework for evaluating cannabis legalization
10:50
to
12:20
Knowledge market 1 (K1)
David Hammond
Oral presentation
2. Patterns of problematic cannabis use among Canadian and US respondents between 2018 and 2020: Findings from the International Cannabis Policy Study
10:50
to
12:20
Knowledge market 1 (K1)
Cesar Leos-Toro
Oral presentation
3. Perceptions of illegal and legal cannabis in Canada in the three years after cannabis legalization: Findings from the International Cannabis Policy Study
10:50
to
12:20
Knowledge market 1 (K1)
TBD TBD
e-poster
Why Social Science should matter for a pragmatic drug policy: Critical analysis of the drug policy debate in India, 1947-2020.
10:50
to
12:20
Networking zone 2 (N2)
Kawal Deep Kour
e-poster
Alcohol industry’s arguments disseminated in the mainstream press against pregnancy alcohol warning labels in France
10:50
to
12:20
Networking zone 2 (N2)
Ana Millot
Oral presentation
2. Streetwork and Outreach Networking
10:50
to
12:20
Knowledge market 4 (K4)
Lagakou Litsa
Oral presentation
3. Direct access to OST treatment and integrated therapy: Lessons learned from streets to community
10:50
to
12:20
Knowledge market 4 (K4)
Nikos Avgerinos
Oral presentation
4. Harm Reduction and Covid 19: Hostel 'IONIS', an example of a holistic intervention for homeless drug users
10:50
to
12:20
Knowledge market 4 (K4)
Foteini Leobilla
Discussion
Challenges faced, political will, societal willingness and community approach of the harm reduction policy.
10:50
to
12:20
Knowledge market 4 (K4)
Athanasios Theocharis
Oral presentation
1. The 4 pillar drug policy and city overview
10:50
to
12:20
Central square 4 (C4)
Andrea Weiss
Oral presentation
3. t-alk' and 'City' – low-threshold meeting places for a diverse clientele
10:50
to
12:20
Central square 4 (C4)
Larissa Stämpfli
Oral presentation
2. Surpervised drug consumption facilities (SDCF)
10:50
to
12:20
Central square 4 (C4)
Janine Lanz
Oral presentation
4. sip züri' - entry control of safe injection facilities, and from social space management to social ambulance
10:50
to
12:20
Central square 4 (C4)
Mara Brügger
Oral presentation
5. Flora Dora' and prostitution area team: outreach social work for sexworkers and low-threshold counselling on the spot
10:50
to
12:20
Central square 4 (C4)
Ursula Kocher
Oral presentation
1. Steps forward in an attempt of OKANA to widen harm reduction to risk reduction: entries and facilities within a new concept based on the real needs
10:50
to
12:20
Knowledge market 4 (K4)
Athanasios Theocharis
13:20
e-poster
Monitoring online drug markets - The darknet project in Zurich
13:20
to
14:50
Networking zone 2 (N2)
Joël Bellmont
e-poster
New trends - The role of Montenegrin criminal groups in international drug crime
13:20
to
14:50
Networking zone 2 (N2)
e-poster
Synthetic drug production and trafficking in Belgium
13:20
to
14:50
Networking zone 2 (N2)
Sophia De Seranno
e-poster
Nicotine content, labelling and flavours of e-liquids in Canada: a scan of the online retail market from 2020-2021
13:20
to
14:50
Networking zone 2 (N2)
Kimberly D'Mello
e-poster
How tiny Albania became the continent’s drug trafficking headquarters. What is the best prevention policy?
13:20
to
14:50
Networking zone 2 (N2)
Sonila Bitri
Oral presentation
3. Municipalities in the lead: an approach to tackle GHB-related problems in the Netherlands.
13:20
to
14:50
Insights zone 2 (I2)
Anneke Van Wamel
e-poster
Exploring the possible human security impact of introducing Blockchain Technologies in Health Canada’s Cannabis supply chain.
13:20
to
14:50
Networking zone 2 (N2)
Stephen Johnson
Oral presentation
1. Development and implementation of an environmental prevention intervention at local level
13:20
to
14:50
Insights zone 2 (I2)
Ina Koning
Oral presentation
2. Choosing our theories wisely: the importance of theory for effective and ethical environmental prevention
13:20
to
14:50
Insights zone 2 (I2)
Angelina Brotherhood
Discussion
What is environmental prevention and its state of development
13:20
to
14:50
Insights zone 2 (I2)
Gregor Burkhart
Oral presentation
1. Cannabis Social Clubs in Europe: a transnational social movement network in the making?
13:20
to
14:50
Knowledge market 4 (K4)
Melissa Bone
Oral presentation
3. Legal or not: a comparative analysis of Belgian and Uruguayan CSC members’ profile and policy preferences
13:20
to
14:50
Knowledge market 4 (K4)
Lorena Repetto
Oral presentation
4. Drug social clubs – the next social club generation?
13:20
to
14:50
Knowledge market 4 (K4)
Chris Wilkins
Oral presentation
2. What are the barriers and prospects for establishing Cannabis Social Clubs in New Zealand?
13:20
to
14:50
Knowledge market 4 (K4)
Marta Rychert
15:00
Short communication
Structured Leisure Activities (SLA) and Adolescent Alcohol Use
15:00
to
16:30
Networking zone 3 (N3)
Matea Belošević
Short communication
Social networks amongst people with alcohol dependence who frequently attend hospital: an exploratory qualitative study
15:00
to
16:30
Networking zone 3 (N3)
Stephanie Fincham-Campbell
Short communication
Alcohol and other drug use and treatment for Aboriginal Australians involved in the criminal justice system
15:00
to
16:30
Networking zone 3 (N3)
Michael Doyle
Short communication
Effectiveness of regulatory policies on online/digital/internet – mediated alcohol marketing: a systematic review
15:00
to
16:30
Networking zone 3 (N3)
Sandra Rados Krnel
Short communication
Outcomes of a health economic evaluation of digital alcohol and tobacco interventions for cancer survivors alongside randomized controlled trials
15:00
to
16:30
Networking zone 3 (N3)
Matthijs Blankers
Short communication
Impact of digital alcohol marketing on alcohol-related attitudes and alcohol consumption
15:00
to
16:30
Networking zone 3 (N3)
Wim Van Dalen
Short communication
Benefits and Challenges of Integrating Yoga in Government-Funded Substance Addiction Treatment Programs in India: Results from a Mixed Methods Research Study with Exploratory Sequential Design.
15:00
to
16:30
Networking zone 3 (N3)
Sebastian Perumbilly,
Jake Zoubek,
Aubrey Grodin
Short communication
The global burden of alcohol use disorders: methodological considerations
15:00
to
16:30
Networking zone 3 (N3)
Laura Jones
Oral presentation
3. The framing of commercial determinants of harm: challenges for regulation in the UK
15:00
to
16:30
Insights zone 3 (I3)
Heather Wardle,
Gerda Reith
Oral presentation
4. Meta-analysis of self-regulation discourses
15:00
to
16:30
Insights zone 3 (I3)
Gerda Reith
Oral presentation
5. Ways gambling industry pursues influence with policymakers
15:00
to
16:30
Insights zone 3 (I3)
Peter J. Adams
Oral presentation
1. State-owned gambling in global competitive environment
15:00
to
16:30
Insights zone 3 (I3)
Johanna Järvinen-Tassopoulos
Oral presentation
2. Where does the gambling surplus come from? Outline of a theory of asymmetric market
15:00
to
16:30
Insights zone 3 (I3)
Pekka Sulkunen
Oral presentation
4. The role of Primary Care in the prevention of drug-related deaths: service provider perspectives
15:00
to
16:30
Knowledge market 1 (K1)
Betsy Thom
Oral presentation
5. Drug Policy and The Rise and Decline of Racial Stratification of Prescribing and Overdose Mortality
15:00
to
16:30
Knowledge market 1 (K1)
Brian Kelly
Oral presentation
1. Drug-related deaths among young people: a social, structural and systems autopsy
15:00
to
16:30
Knowledge market 1 (K1)
Aileen O'Gorman
Oral presentation
2. Drug-related deaths in prisons in England and Wales, 2015-2020: an examination of key trends and issues for policy and practice
15:00
to
16:30
Knowledge market 1 (K1)
Karen Duke
Oral presentation
3. The role of Primary Care in the prevention of drug-related deaths: Patient and family member perspectives
15:00
to
16:30
Knowledge market 1 (K1)
Katie Colliver
Discussion
What can a social, structural and systems analysis tell us about drug-related deaths and what are the implications for policy and addiction science?
15:00
to
16:30
Knowledge market 1 (K1)
Anne Whittaker
Video
1. Equitable Drug Treatment for Migrants and Ethnic Minorities
15:00
to
16:30
Insights zone 1 (I1)
Video
2. Connecting with Care – South Africa
15:00
to
16:30
Insights zone 1 (I1)
Video
3. Prevention of overdose deaths in northern border of Mexico, Tijuana
15:00
to
16:30
Insights zone 1 (I1)
Video
4. REITOX: a model European network bridging science, policy and practice
15:00
to
16:30
Insights zone 1 (I1)
Video
5. While the situation lasts
15:00
to
16:30
Insights zone 1 (I1)
Video
6. The impact of economic recessions on the use of cannabis among young people
15:00
to
16:30
Insights zone 1 (I1)
16:50
Oral presentation
1. A predictive processing account of problem gambling
16:50
to
18:20
Insights zone 3 (I3)
Jarno Tuominen
Oral presentation
2. Flow in (problem) gambling
16:50
to
18:20
Insights zone 3 (I3)
Valtteri Arstila
Oral presentation
3. The ethical implications of how problem gambling is conceptualized
16:50
to
18:20
Insights zone 3 (I3)
Susanne Uusitalo
Oral presentation
Differences in cannabis use and opinions on drug policy between generations
16:50
to
18:20
Central square 2 (C2)
Pekka Hakkarainen
Oral presentation
Adolescent cannabis use during a period of rapid policy change: Evidence from the US PATH Study
16:50
to
18:20
Central square 2 (C2)
Mike Vuolo
Oral presentation
The limitations of decriminalization at overdose events and lessons from an evaluation in British Columbia, Canada
16:50
to
18:20
Knowledge market 1 (K1)
Alissa Greer
Oral presentation
The role played by evidence on the effects of cannabis use in cannabis policy 1992-2022
16:50
to
18:20
Central square 2 (C2)
Eva Hoch
Oral presentation
The change in methadone dispensing requirements in England during the first wave of the COVID-19 pandemic was associated with an increase in deaths from non-prescribed methadone
16:50
to
18:20
Knowledge market 1 (K1)
Caroline Copeland
Oral presentation
Trajectories of Prescribed Medical Cannabis Filled Over Time
16:50
to
18:20
Central square 2 (C2)
Alexandra Kritikos
Oral presentation
Long term public health benefits and cost-effectiveness of two experimental drug consumption rooms in France
16:50
to
18:20
Knowledge market 1 (K1)
Perrine Roux
Oral presentation
The United Kingdom’s first unsanctioned safe injecting facility; a proof-of-concept evaluation
16:50
to
18:20
Knowledge market 1 (K1)
Gillian Shorter
Oral presentation
Medical cannabis regulation: Taking the best of the North American and European models
16:50
to
18:20
Insights zone 2 (I2)
Davide Fortin
Oral presentation
First low-threshold gender responsive residential resource for homeless people using drugs in Barcelona: descriptive evaluation of the first 6 months of activity.
16:50
to
18:20
Knowledge market 1 (K1)
Gabriela Barbaglia
Oral presentation
Municipal variations in cannabis regulation regarding public consumption and retail sales in Canada
16:50
to
18:20
Insights zone 2 (I2)
Christophe Huynh
Oral presentation
Québec's public, not-for-profit cannabis distribution regime: a comparative analysis, three years in
16:50
to
18:20
Insights zone 2 (I2)
François Gagnon
Oral presentation
Regulating Cannabis for Public Health
16:50
to
18:20
Insights zone 2 (I2)
Seema Pessar
Oral presentation
Mitigating the risks of corporate capture in emerging legal cannabis markets
16:50
to
18:20
Insights zone 2 (I2)
Stephen Rolles
Oral presentation
Equity in Marijuana Policies: A Comparative Study of two U.S. States using Critical Race Theory.
16:50
to
18:20
Insights zone 2 (I2)
Gaby Mohr
Discussion
European Prevention Curriculum
16:50
to
18:20
Networking zone 2 (N2)
Gregor Burkhart
Oral presentation
1. Assisting drug policies in the quest for an evidence-base: challenges related to the development of a National Action Plan for the Drug Information System
16:50
to
18:20
Networking zone 2 (N2)
Viktor Mravcik
Oral presentation
2. Shared responsibilities among different stakeholders in the quest for evidence: experiences from Georgia
16:50
to
18:20
Networking zone 2 (N2)
Ketevan Sarajishvili
Oral presentation
6. European Prevention Curriculum – a tool for disseminating effective modern prevention approaches and facilitating well-informed choices about funding and implementation priorities: reflections from Georgia
16:50
to
18:20
Networking zone 2 (N2)
Jana D. Javakhishvili
Oral presentation
3. Capacity building for practitioners on evidence-based drug treatment interventions aligned with EU quality standards and tailored to national needs
16:50
to
18:20
Networking zone 2 (N2)
Anna Tarján
Oral presentation
4. Capacity building for practitioners on evidence-based drug treatment interventions aligned with EU quality standards and tailored to national needs: reflections from Georgia
16:50
to
18:20
Networking zone 2 (N2)
David Otiashvili
Oral presentation
5. The importance of an evidence-based approach in the development of a national drug policy
16:50
to
18:20
Networking zone 2 (N2)
Artur Malczewski
Oral presentation
Signals from the future: Exploring implications for drug policies
16:50
to
18:20
Central square 4 (C4)
Laura Smit-rigter
Friday, 25 November
09:00
Keynote presentation
A social inequities viewpoint to reducing alcohol-related harm
09:00
to
10:30
Main stage
Pia Mäkelä
Keynote presentation
What did we learn about recent trends in underage drinking: Secular trends, shifts, and relations to other substance use
09:00
to
10:30
Main stage
Jasmina Burdzovic
Keynote presentation
Can brief interventions ever really take on the alcohol industry and win?
09:00
to
10:30
Main stage
Jim McCambridge
10:50
Oral presentation
An online gambling intervention using the realization effect
10:50
to
12:20
Insights zone 3 (I3)
Ke Zhang
Oral presentation
Consumer Protection and Responsible Gambling Practices in Crypto Casinos
10:50
to
12:20
Insights zone 3 (I3)
Steve Sharman
Oral presentation
The development of a disclaimer to accompany marketing and recruitment efforts for gambling products
10:50
to
12:20
Insights zone 3 (I3)
Anouk Tuijnman
Oral presentation
Why did New Zealand’s referendum to legalise recreation cannabis fail? An analysis of media campaigns and predictors of voter support for cannabis legalisation in New Zealand
10:50
to
12:20
Knowledge market 1 (K1)
Marta Rychert
Oral presentation
Language matters and it starts with us: How to talk about drugs to advocate for reform more effectively
10:50
to
12:20
Knowledge market 1 (K1)
Alice Salomon
Oral presentation
The Policy Constellation Approach: application of a critical realist public policy theory to the explanation of the UK’s drug strategy for 2021-2031
10:50
to
12:20
Knowledge market 1 (K1)
Alex Stevens
Oral presentation
The utility of different values frameworks for drug policy analysis
10:50
to
12:20
Knowledge market 1 (K1)
Alison Ritter
Oral presentation
5. Drug use among non-binary persons in Europe: findings from a web survey
10:50
to
12:20
Networking zone 3 (N3)
Cristiana Vale Pires
Oral presentation
1. What is gender and why it is necessary to incorporate a gender perspective in the drug field? Evolution of key theoretical concepts in the area of gender and trends influencing the drug field
10:50
to
12:20
Networking zone 3 (N3)
Analia Torres
Oral presentation
2. Gender differences in drug use from a social perspective
10:50
to
12:20
Networking zone 3 (N3)
Nuria Romo
Oral presentation
3. Sex differences in drug use and drug addiction from a neuroscience perspective
10:50
to
12:20
Networking zone 3 (N3)
Anne Marije Kaag
Oral presentation
4. Using an intersectional risk environment approach to understand health and drug outcomes: Looking across social locations
10:50
to
12:20
Networking zone 3 (N3)
Alexandra B. Collins
Oral presentation
6. Implementing a gender dimension in drug policy and practice: findings from the Pompidou Group handbook for practitioners and decision makers
10:50
to
12:20
Networking zone 3 (N3)
Sarah Morton
Oral presentation
3. Harm Reduction and Public Health: The place of 'subjugated knowledges'
10:50
to
12:20
Central square 2 (C2)
Daniel Martins
Oral presentation
1. How to reduce drug-related crimes
10:50
to
12:20
Central square 2 (C2)
Jorge Quintas
Oral presentation
2. 20 years of Portuguese drug policy: developments and current challenges
10:50
to
12:20
Central square 2 (C2)
Ximene Rêgo
Oral presentation
4. Drug consumption rooms in Lisbon: lessons learned
10:50
to
12:20
Central square 2 (C2)
Adriana Curado
Oral presentation
5. A strategy for all drug uses
10:50
to
12:20
Central square 2 (C2)
Maria Carmo Carvalho
Discussion
Recent developments in the gender field: the EIGE’s perspective
10:50
to
12:20
Networking zone 3 (N3)
Oral presentation
Troubling trends in global alcohol consumption and harms
10:50
to
12:20
Main stage
Jürgen Rehm
Oral presentation
2. Changing risk perception on alcohol consumption
10:50
to
12:20
Main stage
Carina Ferreira-Borges
Oral presentation
3. The Gut-Brain Axis in AUD - still valid?
10:50
to
12:20
Main stage
Philippe de Timary
Oral presentation
1. Presentation of the project "Alcohol no ordinary commodity (ANOC) vx 3"
10:50
to
12:20
Main stage
Jürgen Rehm
Oral presentation
Optimising digital tools for substance use and substance use disorders by 2030: a backcasting exercise
10:50
to
12:20
Insights zone 1 (I1)
Elsa Caballeria,
AbuTaher AbuTaher,
Florian Scheibein
4. The EUFAS-EAR European Addiction Award 2022
10:50
to
12:20
Main stage
13:20
Oral presentation
Cannabis regulation and fiscal policy: Opportunities for human rights in Colombia
13:20
to
14:50
Knowledge market 1 (K1)
Luis Felipe Cruz-olivera
Oral presentation
Prioritising measures to assess performance of drug treatment services: perspectives of funders, treatment providers and service users
13:20
to
14:50
Knowledge market 1 (K1)
Robert Stirling
Oral presentation
Tracking the illicit Cannabis Market during the closed Cannabis Supply Chain Experiment in Netherlands using an online Crowdsourcing Approach
13:20
to
14:50
Knowledge market 1 (K1)
Stijn Hoorens
Oral presentation
The effects of cannabis liberalization laws on health, safety, and socioeconomic outcomes: An evidence and gap map
13:20
to
14:50
Knowledge market 1 (K1)
Eric Sevigny
Oral presentation
Triangulating wastewater and a prospective survey of drug consumption – new insights for policy makers
13:20
to
14:50
Knowledge market 1 (K1)
Caitlin Hughes